87 related articles for article (PubMed ID: 6453494)
21. Production of human T cell colony-inducing activity (TCI) by malignant cells from patients with lymphocytic and myeloid leukemia.
Douer D; Sachs L
J Immunol; 1979 Jun; 122(6):2473-7. PubMed ID: 312870
[No Abstract] [Full Text] [Related]
22. Surface antigens on leukaemic myeloid cells. I. Distribution and movement of antigens reacting to antilymphocytic globulins.
Bacigalupo A; Santini G; Piaggio G; Giordano D; Marmont AM
Haematologica; 1977 Apr; 62(2):136-43. PubMed ID: 406171
[No Abstract] [Full Text] [Related]
23. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
[TBL] [Abstract][Full Text] [Related]
24. [Responsiveness of lymphocytes to stimulation by pha and autologous blasts in acute lymphatic leukemias during remission (author's transl)].
Rella W; Pawlowsky J; Krepler P; Kummer M
Padiatr Padol; 1976; 11(2-2):364-8. PubMed ID: 135240
[TBL] [Abstract][Full Text] [Related]
25. Mixed cell cultures of normal and leukaemic cells.
Pegrum GD; Balfour IC; Evans CA; Middleton VL
J Pathol; 1973 May; 110(1):59-66. PubMed ID: 4269239
[No Abstract] [Full Text] [Related]
26. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
[TBL] [Abstract][Full Text] [Related]
27. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. I. Role of HLA-DR antigens as stimulatory molecules.
Matera L; Francis MK; Herlyn M; Trucco M; Santoli D
Nat Immun Cell Growth Regul; 1985; 4(2):90-102. PubMed ID: 3160934
[TBL] [Abstract][Full Text] [Related]
28. Expression of human B-lymphocyte antigens by most lymphocytic and myelocytic leukemia cells.
Billing RJ; Ting A; Terasaki PI
Transplant Proc; 1977 Mar; 9(1):1145-7. PubMed ID: 68565
[No Abstract] [Full Text] [Related]
29. [Lymphocyte surface markers and clinical course in acute lymphocytic leukemia (author's transl)].
Matsuyama S; Ohnishi S; Kawashima T; Osada S; Sasaki H
Rinsho Ketsueki; 1976 Jul; 17(7):758-63. PubMed ID: 1068313
[No Abstract] [Full Text] [Related]
30. Immune reactivity of leukemia patients to autologous blast cells.
Leventhal BG; Halterman RH; Rosenberg EB; Herberman RB
Cancer Res; 1972 Sep; 32(9):1820-5. PubMed ID: 4264526
[No Abstract] [Full Text] [Related]
31. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells.
Pegrum GD; Evans CA; Middleton VL; Balfour IC
Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
Rodey GE; Sprader JC; Bortin MM
Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
[No Abstract] [Full Text] [Related]
33. [Cell reactions of immunological significance studied in bone marrow and lymph node cultures].
Berceanu S; Gociu M; Răileanu-Moţoiu I
Arch Roum Pathol Exp Microbiol; 1969; 28(2):453-64. PubMed ID: 5275846
[No Abstract] [Full Text] [Related]
34. Alloantisera to human leukemic blast cells: detection of leukemia-associated antigens (LAA).
Baker MA; Falk JA; Taub RN
Prog Clin Biol Res; 1977; 16():103-7. PubMed ID: 71741
[No Abstract] [Full Text] [Related]
35. [Studies on purine de novo synthesis and cyclic AMP in normal and pathologic leukocytes (author's transl)].
Schwarzmeier JD
Wien Klin Wochenschr; 1974 Dec; 86(23):716-24. PubMed ID: 4373939
[No Abstract] [Full Text] [Related]
36. Suppressor substance produced by the K562 cell line in vitro.
Korzelius JM; Bealmear PM; Holtermann OA
J Surg Oncol; 1983 May; 23(1):16-20. PubMed ID: 6221160
[TBL] [Abstract][Full Text] [Related]
37. [Lymphocyte blastogenesis in vitro in leukemias and lymphomas of childhood].
Fabris C; De Sanctis C; Ponzone A
Minerva Pediatr; 1971 Feb; 23(5):194-8. PubMed ID: 5280413
[No Abstract] [Full Text] [Related]
38. The HLA system and survival in malignant disease: Hodgkin's disease and carcinoma of the breast.
Falk J; Osoba D
Prog Clin Biol Res; 1977; 16():205-19. PubMed ID: 143666
[No Abstract] [Full Text] [Related]
39. Cell surface markers and kinetic features in acute lymphoblastic leukaemia.
Caligaris Cappio F; Novarino A; Matera L; Gavosto F
Haematologica; 1981 Aug; 66(4):419-25. PubMed ID: 6797877
[No Abstract] [Full Text] [Related]
40. Enhancement of "one-way" human mixed lymphocyte reaction by cholinergic agents.
Han T
Clin Exp Immunol; 1976 Aug; 25(2):338-41. PubMed ID: 133778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
